GO
Loading...

Biotech weighs on S&P

Friday, 21 Mar 2014 | 1:02 PM ET

CNBC's Dominic Chu reports the health care sector is being dragged down by the biotech sector. Congressional Democrats asked biotech company Gilead to provide insight on pricing for its hepatitis C drug Sovaldi.